3,4-Dimethoxyphenethylamine synthesis of Bevantolol. DMPEA has some activity as a monoamine oxidase inhibitor. DMPEA occurs naturally along with mescaline in various species of cacti such as San Pedro and Peruvian Torch. 3,4-Dimethoxyphenethylamine 3,4-Dimethoxyphenethylamine (DMPEA) is a chemical compound of the phenethylamine class. It is an analogue of the major human neurotransmitter dopamine where the 3- and 4-position hydroxy groups have been replaced with methoxy groups. It is also closely related to mescaline which is 3,4,5-trimethoxyphenethylamine. One of the earliest syntheses of DMPEA (then referred to as "homoveratrylamine") was that of Pictet and Finkelstein, who made it in a multi-step sequence starting
Mescaline deemed too controversial and ultimately omitted from the show, Mayhew praised the experience, calling it "the most interesting thing I ever did". Mescaline has a wide array of suggested medical usage, including treatment of alcoholism and depression. However, its status as a Schedule I controlled substance in the Convention on Psychotropic Substances limits availability of the drug to researchers. Because of this, very few studies concerning mescaline's activity and potential therapeutic effects in humans have been conducted since the early 1970s. Mescaline is biosynthesized from tyrosine or a hydroxylated phenylalanine. In "Lophophora williamsii" (Peyote), dopamine converts into mescaline in a